Post
Virion reports safety data from Phase IB HBV immunotherapy trial
Virion Therapeutics has reported encouraging safety outcomes from the first-in-human Phase IB clinical study of VRON-0200, a checkpoint modifier immunotherapy …
Beckley Psytech reports initial positive data from TRD treatment trial
Beckley Psytech has released initial positive findings from its Phase IIa clinical study of BPL-003 for treating treatment-resistant depression (TRD). The …
89bio wins EMA priority status for MASH candidate pegozafermin
The European Medicine’s Agency (EMA) has granted priority medicines (PRIME) status to 89bio’s pegozafermin, a drug being evaluated to treat …
Pfizer’s Velsipity UK approval raises competition in the ulcerative colitis market
The recent approval of Pfizer’s oral drug, Velsipity (etrasimod), by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for …
Cleerly touts new data for AI cardiovascular software
Digital healthcare company Cleerly has announced that positive data from two studies investigating its AI-QCT ISCHEMIA software device has been …
Beckley Psytech reports initial positive data from TRD treatment trial
Beckley Psytech has released initial positive findings from its Phase IIa clinical study of BPL-003 for treating treatment-resistant depression (TRD). The …
89bio wins EMA priority status for MASH candidate pegozafermin
The European Medicine’s Agency (EMA) has granted priority medicines (PRIME) status to 89bio’s pegozafermin, a drug being evaluated to treat …
Pfizer’s Velsipity UK approval raises competition in the ulcerative colitis market
The recent approval of Pfizer’s oral drug, Velsipity (etrasimod), by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for …
Cleerly touts new data for AI cardiovascular software
Digital healthcare company Cleerly has announced that positive data from two studies investigating its AI-QCT ISCHEMIA software device has been …
Implantica gears up for FDA approval of acid reflux device
Implantica has started the premarket approval process with the US Food and Drug Administration (FDA) for its gastroesophageal reflux disease …
Oncology in 2024: The clinical trial trends reshaping the role of CROs
Oncology is the most active area in clinical trials globally this year, as more resources than ever are being dedicated …
Auxilius Pharma to launch Phase Ib anti-anginal trial after IND application
Auxilius Pharma will be submitting an investigative new drug (IND) application for AUX-001 with plans to initiate a Phase Ib …
Atamyo obtains clearance for muscular dystrophy gene therapy trial in Europe
Atamyo Therapeutics has received regulatory clearance in Europe to initiate a Phase Ib clinical trial for its gene therapy, ATA-200, …
Valneva commences Phase I trial of second-generation Zika vaccine
Valneva has commenced the Phase I VLA1601-102 clinical trial of its second-generation adjuvanted inactivated vaccine candidate, VLA1601, against the Zika …
Viking reports positive data from Phase I oral obesity treatment trial
Viking Therapeutics has reported positive data from its Phase I multiple ascending dose (MAD) clinical trial of VK2735, an oral …